ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Overview Fund Activity
Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

47 hedge funds and large institutions have $24.7M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 10 closing their positions.

Holders
47
Holders Change
-3
Holders Change %
-6%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
12
Closed
10
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$4K

Top Buyers

1
CA
1
CHI Advisors
New York
$3.99M
2
Citadel Advisors
2
Citadel Advisors
Florida
$1.15M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$549K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.27M
5
MIAN
5
Mariner Independent Advisor Network
Kansas
$258K

Top Sellers

1
Artisan Partners
1
Artisan Partners
Wisconsin
$0
2
RCM
2
RA Capital Management
Massachusetts
$0
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$111K
4
GCP
4
GSA Capital Partners
United Kingdom
$0
5
UOC
5
UBS O'Connor
Illinois
$216K
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
$0 753 -6,467 -90%
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$0 9 -2,000 -100%
CWP
53
Concord Wealth Partners
Virginia
– – -1,000 Closed
CAPTRUST Financial Advisors
54
CAPTRUST Financial Advisors
North Carolina
– – -750 Closed
CFGS
55
Concourse Financial Group Securities
Alabama
– – – –
MAWCM
56
Mine & Arao Wealth Creation & Management
California
$0 100 – –
BHWM
57
Beaird Harris Wealth Management
Texas
$0 120 +120 New
Simplex Trading
58
Simplex Trading
Illinois
$0 1,870 +1,000 +115%
1 2
3